Managing Director
anne.wallis@hiphealth.ca
Dr. Anne Wallis has a background in science (Molecular Biology PhD) and management that is key to her role in integrating the research and operational components of the CHHM. Dr. Wallis previously co-founded a biopharmaceutical company (Celator Technologies Inc.), where she served as Chief Operating Officer, advancing the company from its early stage as a university spin-off to an established venture capital-funded organization. She has substantial experience in strategic leadership and management, including successful fundraising within major programs supported by the Leading Edge Endowment Fund, the High Tech/New Emerging Technologies Fund, and the Provincial Health Services Authority.